How to Prevent Lymphoma: Reducing Your Risk

Lymphoma has no single preventable cause, which makes “prevention” a different conversation than it is for, say, lung cancer or melanoma. Most people who develop lymphoma have no obvious controllable risk factor. Still, research has identified several exposures, infections, and lifestyle patterns that shift your odds in meaningful ways. Some of these you can act on directly; others are worth knowing about so you can work with your doctor to monitor the right things.

Infections That Drive Lymphoma and What You Can Do About Them

Several common infections are directly linked to specific lymphoma types, and treating or preventing those infections is one of the few clear-cut strategies for reducing risk.

Helicobacter pylori is the bacterium behind most stomach ulcers, and it also fuels a type of lymphoma called gastric MALT lymphoma. The connection is strong enough that standard antibiotic treatment for the infection is now used as first-line therapy for this lymphoma. A large study found that after antibiotic eradication therapy, over 80% of patients with gastric MALT lymphoma achieved complete remission, with even some H. pylori-negative patients responding.¹ That means getting tested and treated for H. pylori if you have symptoms like chronic stomach pain or ulcers is both good gastric medicine and, in a real sense, lymphoma prevention. The typical treatment is a short course of antibiotics combined with an acid-lowering drug.²

Chronic hepatitis C virus (HCV) infection also raises lymphoma risk. In a large study, patients with untreated HCV had a significantly higher rate of lymphoma than those who received antiviral therapy. Among patients under 60, treatment cut all-lymphoma risk by roughly half and non-Hodgkin lymphoma (NHL) risk by about 48%.³ An important wrinkle: that study used older interferon-based therapy. A separate analysis found that the newer direct-acting antivirals (DAAs), which are now standard, did not show the same reduction in lymphoma risk during a roughly three-year follow-up, though the follow-up period was relatively short.⁴ Whether that gap closes with longer follow-up remains an open question. Regardless, curing hepatitis C has overwhelming health benefits and remains recommended.

HIV dramatically increases lymphoma risk. In the early antiretroviral therapy era, people living with HIV had NHL rates more than five times those of uninfected individuals. Effective antiretroviral therapy has cut that rate by more than half over the past two decades.⁵ For Hodgkin lymphoma the picture is different: despite antiretroviral therapy, Hodgkin lymphoma rates in people with HIV remain five- to fifteen-fold higher than in the general population and have not declined the same way.⁶ Higher viral load appears to be associated more strongly with NHL than with Hodgkin lymphoma, which may partly explain why suppressing the virus helps more for one than the other.⁷ The practical takeaway: if you are living with HIV, staying on antiretroviral therapy and keeping viral load suppressed is one of the most important things you can do for lymphoma risk.

Epstein-Barr virus (EBV) is linked to several lymphoma types, including Burkitt lymphoma and some Hodgkin lymphoma cases. Research has found that people who go on to develop Burkitt lymphoma tend to have distinctly higher immune responses to EBV proteins beforehand, suggesting the virus plays an active role long before diagnosis.⁸ Unfortunately, there is no vaccine or standard prevention strategy for EBV yet, though vaccines are in development. For now, EBV is a risk factor you can be aware of but cannot directly control.

Smoking and Lymphoma

Smoking does not cause lymphoma the way it causes lung cancer, but the association is real and consistent enough to matter. A meta-analysis across many studies found that ever-smokers had a modestly elevated risk of both NHL and Hodgkin lymphoma. The association was strongest for Hodgkin lymphoma, and among NHL subtypes, T-cell lymphoma showed a clearer link.⁹ For follicular lymphoma specifically, an Australian case-control study found that ever-smokers had roughly 40% higher odds, with risk climbing with more pack-years.¹⁰

The relationship may also depend on your genetics. One study found that among people carrying certain immune-system gene variants, current smokers had more than triple the odds of follicular lymphoma compared to never-smokers without those variants. Among people lacking those gene variants, smoking showed no significant association.¹¹ You cannot know your specific genetic susceptibility in advance, which makes quitting (or never starting) the practical move.

Occupational and Chemical Exposures

If you work in agriculture, manufacturing, or any trade involving chemical solvents, your lymphoma risk profile differs from the general population’s. The evidence here is strong enough to inform real workplace decisions.

Pesticide exposure is one of the better-established occupational risk factors. A European case-control study found that substantial exposure to pesticides of any kind was associated with roughly triple the risk of NHL.¹² The Agricultural Health Study, which followed farmers and pesticide applicators in the United States, identified specific agents: lindane and DDT showed significant dose-response trends with NHL overall, while other compounds like terbufos and diazinon were linked to particular subtypes.¹³ For most readers, the actionable point is straightforward: if you handle pesticides, use proper protective equipment, minimize skin contact, and follow safety guidelines carefully.

Benzene is another well-documented risk factor. A systematic review and meta-analysis found that high benzene exposure was associated with about a 33% increased risk of NHL overall, and the risk roughly doubled for diffuse large B-cell lymphoma specifically.¹⁴ The Epilymph case-control study across several European countries confirmed that exposure to benzene, toluene, xylene, and other industrial solvents significantly increased risk of follicular lymphoma and chronic lymphocytic leukemia.¹⁵ These are primarily occupational exposures that affect people working in petrochemical plants, rubber manufacturing, gasoline distribution, and similar industries. For the general public, benzene exposure is usually very low, but it is worth noting that gasoline and cigarette smoke are common low-level sources.

PFAS and Other Emerging Concerns

Per- and polyfluorinated substances, the so-called “forever chemicals” found in nonstick cookware, waterproof clothing, and contaminated water supplies, have raised concerns about cancer risk. When it comes to lymphoma, the evidence so far is mixed and mostly reassuring at general-population exposure levels. A prospective cohort study using serum samples found no overall association between the five most common PFAS chemicals and B-cell NHL.¹⁶ However, one specific compound, PFHxS, showed a suggestive link with diffuse large B-cell lymphoma, and a separate study in the American Cancer Society cohort found a positive association between PFHxS and chronic lymphocytic leukemia in men.¹⁷ The research is at an early stage. Reducing PFAS exposure is sensible for many health reasons, but you should not panic over lymphoma specifically based on current data.

Body Weight, Diet, and Exercise

The relationship between body weight and lymphoma is surprisingly weak compared to many other cancers. A large pooled analysis from the InterLymph Consortium found no association between severe obesity and NHL overall. There was one exception: people with a body mass index of 40 or above had about 80% higher odds of diffuse large B-cell lymphoma specifically.¹⁸ A separate meta-analysis of prospective studies found a small but consistent effect: for every five-unit increase in BMI, NHL risk rose about 7%, and Hodgkin lymphoma risk was about 40% higher in obese compared to normal-weight individuals.¹⁹ So maintaining a healthy weight is worth doing, but the effect on lymphoma risk specifically is modest.

Diet studies paint a complicated picture. A case-control study identified a dietary pattern heavy in red and processed meat, fried food, sweets, and sugary drinks as associated with roughly three to four times higher NHL risk when comparing the highest intake to the lowest.²⁰ A Spanish study found a similar pattern: high adherence to a Western diet was linked to higher risk of chronic lymphocytic leukemia.²¹ On the flip side, eating a plant-heavy diet did not show a protective effect in either study, and a Mediterranean-focused study found no protection from adhering to that pattern either.²² The pattern across these studies suggests that it is the worst dietary habits that raise risk rather than any specific “healthy” diet that lowers it.

Physical activity may offer a small protective benefit. A systematic review and meta-analysis found that the most physically active people had about 11% lower risk of developing any lymphoma compared to the least active.²³ That is a real but small effect, and it was more consistent in case-control studies than in cohort studies, which makes the finding a little less certain. Exercise has such strong benefits for so many other conditions that recommending it for lymphoma risk alone would overstate the evidence, but it is one more reason to stay active.

The Alcohol Paradox

Here is one that goes against intuition. Pooled analyses have consistently found that alcohol consumption is associated with lower NHL risk, not higher. The protective association does not vary much by beverage type and appears across multiple NHL subtypes, with some of the strongest reductions seen in Burkitt lymphoma.²⁴ A large American Cancer Society cohort study found that alcohol intake was significantly inversely associated with B-cell lymphoma.²⁵ No one recommends drinking to prevent lymphoma, and alcohol raises the risk of several other cancers. But it is worth knowing about because it illustrates how lymphoma’s risk profile does not always line up with what you would expect from other cancers.

Sunlight and Lymphoma

Another counterintuitive finding: sun exposure appears to be associated with lower NHL risk. A Scandinavian case-control study found that people who reported frequent sunbathing and sunburns in their twenties had 30-40% lower odds of NHL compared to those who rarely spent time in the sun.²⁶ These inverse associations strengthened with increasing levels of exposure. The mechanism likely involves vitamin D or immune modulation from UV radiation, though this is still debated. As with alcohol, this does not mean you should throw away sunscreen, because skin cancer risk is real and well-established. But it is another reminder that lymphoma has its own biology and does not follow the rules that apply to solid tumors.

Autoimmune Conditions and Immune Suppression

Chronic inflammation from autoimmune disease is a well-established lymphoma risk factor. Conditions like Sjögren’s syndrome, rheumatoid arthritis, systemic lupus, and celiac disease have all been linked to elevated lymphoma risk, with more severe and active disease carrying higher risk.²⁷ Different autoimmune diseases tend to be associated with different lymphoma subtypes. Sjögren’s syndrome, for instance, is tied to MALT lymphoma, while celiac disease is associated with a specific intestinal lymphoma.

If you have an autoimmune condition, the practical advice is to work with your doctor to keep inflammation well controlled. You cannot eliminate lymphoma risk from autoimmune disease entirely, but poorly managed chronic inflammation appears to be worse than well-managed disease.

Organ transplant recipients face a distinct form of lymphoma risk. The immunosuppressive drugs needed to prevent organ rejection can lead to post-transplant lymphoproliferative disorder (PTLD), a condition that ranges from benign overgrowth to aggressive lymphoma. The risk varies by organ: roughly 1-2% after kidney transplant, rising to as high as 10% after heart or lung transplant, reflecting the more intensive immunosuppression required for thoracic organs.²⁸ EBV infection is a major driver of PTLD, and the degree of immunosuppression is the other key factor.²⁹ Lowering maintenance immunosuppression to the minimum effective dose and using drugs that inhibit cell proliferation are strategies transplant teams use to reduce PTLD risk.²⁸ If you are a transplant recipient, this is managed by your transplant team, but being aware of the connection is useful.

Breast Implants and a Rare Lymphoma

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare but real entity that gained significant attention in the 2010s. It occurs almost exclusively with textured-surface implants, not smooth ones. In a Dutch cohort that followed over 3,500 women with textured implants for a median of nearly 12 years, 10 developed BIA-ALCL, all with macro-textured devices.³⁰ An Australian study estimated the incidence at about 1 in 559 patients with textured implants, with a median time to diagnosis of about 10 years.³¹ Broader epidemiological estimates suggest the risk may be roughly 1 in 355 patients with textured implants used for breast reconstruction.³²

Several countries have now banned the most aggressively textured implants. If you are considering breast implants, this is worth discussing with your surgeon. Smooth implants have not been linked to this lymphoma. If you already have textured implants and are asymptomatic, professional guidelines generally do not recommend prophylactic removal, but you should be aware that persistent swelling, pain, or fluid collection around the implant should be evaluated promptly.

Hair Dye and Consumer Products

The link between personal hair dye use and lymphoma has been studied extensively and is less alarming than it once seemed. A Connecticut population-based study found that women who began using hair dye before 1980 had a modestly elevated risk of NHL, but women who started in 1980 or later showed no increased risk at all.³³ The most likely explanation is that hair dye formulations changed substantially in the late 1970s, when several known carcinogens were removed. If you currently use hair dye, the available evidence does not suggest meaningful lymphoma risk from modern formulations.

Family History and Genetic Risk

Lymphoma does run in families to a degree. First-degree relatives of someone with NHL have about 1.7 times the average person’s risk of developing it. For Hodgkin lymphoma the familial risk is roughly threefold, and for chronic lymphocytic leukemia it is particularly high, at about 8.5 times the general population risk.³⁴ These risks sound alarming in relative terms but matter less in absolute terms because lymphoma is uncommon to begin with. Even an 8.5-fold increase in CLL risk means going from very rare to uncommon. There is currently no recommended screening test for lymphoma in high-risk families, which limits what you can do with this information beyond staying attentive to unexplained symptoms like persistent swollen lymph nodes, fevers, night sweats, and unintentional weight loss.

CT Scans and Medical Radiation

Concern about medical imaging and cancer risk is common, and for lymphoma specifically, the data is nuanced. A large study found no overall association between CT scan exposure and NHL in the general patient population. However, among patients 45 or younger, an increased risk was observed.³⁵ This fits the broader understanding that younger tissues are more sensitive to radiation effects. None of this means you should refuse a medically necessary CT scan. The risk from a single scan is extremely small, and the diagnostic information usually far outweighs it. But avoiding unnecessary imaging, especially in younger patients, is reasonable practice for many cancer types.

1
PubMed Central. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori -Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
2
PubMed. Treatment of gastric MALT lymphoma with a focus on Helicobacter pylori eradication
3
PubMed. Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection
4
PubMed Central. Eradication of Hepatitis C Virus Is Associated With Reduction in Hematologic Malignancies: Major Differences Between Interferon and Direct-Acting Antivirals
5
PubMed Central. Time trends in cancer incidence in persons living with HIV/AIDS in the antiretroviral therapy era: 1997–2012
6
PubMed Central. Impact of highly effective antiretroviral therapy on the risk for Hodgkin lymphoma among people with human immunodeficiency virus infection
7
JNCI: Journal of the National Cancer Institute. Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma
8
Cancer Epidemiology, Biomarkers & Prevention. Abstract 60: Discovery of Epstein-Barr Virus Antibody Seroprofiles Associated with Burkitt Lymphoma Risk in East Africa
9
European Journal of Cancer Prevention. Cigarette smoking and risk of lymphoma in adults
10
PubMed Central. Associations between Smoking and Alcohol and Follicular Lymphoma Incidence and Survival: A Family-Based Case-Control Study in Australia
11
PubMed. Possible Interaction Between Cigarette Smoking and HLA-DRB1 Variation in the Risk of Follicular Lymphoma
12
American Journal of Epidemiology. Occupational Exposure to Pesticides and Risk of Non-Hodgkin’s Lymphoma
13
PLOS ONE. Non-Hodgkin Lymphoma Risk and Insecticide, Fungicide and Fumigant Use in the Agricultural Health Study
14
PubMed Central. Benzene exposure and non-Hodgkin lymphoma: a systematic review and meta-analysis of human studies
15
PubMed. Occupational exposure to solvents and risk of lymphoma subtypes: results from the Epilymph case-control study
16
PubMed Central. Serum concentrations of per- and polyfluorinated substances and risk of B-cell non-Hodgkin lymphoma
17
PubMed Central. Case–Cohort Study of the Association between PFAS and Selected Cancers among Participants in the American Cancer Society’s Cancer Prevention Study II LifeLink Cohort
18
PubMed Central. Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium
19
PubMed. Body mass index and risk of non-Hodgkin’s and Hodgkin’s lymphoma: a meta-analysis of prospective studies
20
PubMed Central. Dietary patterns and the risk of non-Hodgkin lymphoma
21
PubMed Central. Adherence to the Western, Prudent, and Mediterranean dietary patterns and chronic lymphocytic leukemia in the MCC-Spain study
22
PubMed. Risk of lymphoma subtypes and dietary habits in a Mediterranean area
23
BMC Cancer. The relationship between physical activity and lymphoma: a systematic review and meta analysis
24
The Lancet Oncology. Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis
25
American Journal of Epidemiology. Alcohol Intake and the Incidence of Non-Hodgkin Lymphoid Neoplasms in the Cancer Prevention Study II Nutrition Cohort
26
PubMed. Ultraviolet radiation exposure and risk of malignant lymphomas
27
PubMed. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics
28
PubMed. Lymphoproliferative disorders after solid organ transplantation-classification, incidence, risk factors, early detection and treatment options
29
PubMed Central. Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies
30
PubMed Central. Risk of Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) in a Cohort of 3546 Women Prospectively Followed Long Term After Reconstruction with Textured Breast Implants
31
PubMed Central. Breast Implant-Associated Anaplastic Large Cell Lymphoma Incidence: Determining an Accurate Risk
32
PubMed Central. New Data on the Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma
33
American Journal of Epidemiology. Hair-coloring Product Use and Risk of Non-Hodgkin’s Lymphoma: A Population-based Case-Control Study in Connecticut
34
PubMed Central. Familial predisposition and genetic risk factors for lymphoma
35
PubMed Central. Exposure to Tomographic Scans and Cancer Risks